Class I and II HLA genes are associated with susceptibility and age at onset in Finnish families with type 1 diabetes

Human Heredity

Volumn 57, Issue 2, 2004, Pages 69-79

  Pitkäniemi, Janne ^a,b   Hakulinen, Timo ^a   Näsänen, Jurkka ^b   Tuomilehto Wolf, Eva ^b   Tuomilehto, Jaakko ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Age at onset; Ascertainment; HLA; Susceptibility; T1DM

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA B60 ANTIGEN; HLA B62 ANTIGEN; HLA B8 ANTIGEN; HLA DR ANTIGEN; HLA DR3 ANTIGEN; HLA DR6 ANTIGEN; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ETHNIC GROUP; FAMILY; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HLA ANTIGEN CLASS 1 GENE; HLA ANTIGEN CLASS 2 GENE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LATENT PERIOD; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MODEL; ONSET AGE; PARAMETER; POPULATION RESEARCH; REGISTER; RISK ASSESSMENT; SIBLING; SIMULATION; SURVIVAL TIME; TIME;

AGE FACTORS; ALLELES; DIABETES MELLITUS, TYPE 1; FAMILY; FINLAND; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GENOTYPE; HLA ANTIGENS; QUANTITATIVE TRAIT LOCI; RETROSPECTIVE STUDIES;

EID: 2942740982     PISSN: 00015652     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077544     Document Type: Article

References (30)

1. Pajunen P: Studies on the severity and extent of coronary atherosclerosis utilizing computer-assisted quantification of coronary angiograms with special reference to diabetes mellitus, dissertation, University of Helsinki, 2002.
2. Karvonen M, Pitkaniemi J, Tuomilehto J: The onset age of type 1 diabetes in Finnish children has become younger. The Finnish Childhood Diabetes Registry Group. Diabetes Care 1999;22:1066-1070.
3. Dahlquist G, Mustonen L: Analysis of 20 years of prospective registration of childhood onset diabetes time trends and birth cohort effects. Swedish Childhood Diabetes Study Group. Acta Paediatr 2000;89:1231-1237.
4. Onkamo P, Väänänen S, Karvonen M, Tuomilehto J: Worldwide increase in incidence of type I diabetes - the analysis of the data on published incidence trends. Diabetologia 1999;42:1395-1403.
5. Tuomilehto-Wolf E., Tuomilehto J, and the DiMe Study Group: Is the high incidence of diabetes in young children diagnosed under 4 years determined by genetic factors in Finland? Diabete Metabolisme 1993;19:167-172.
6. Thompson G: HLA disease associations: models for insulin dependent diabetes mellitus and the study of complex human disorders. Annu Rev Genet 1988;22:31-50.
7. Tuomilehto-Wolf E, Tuomilehto J: HLA antigen in insulin-dependent diabetes mellitus. Ann Med 1991;23:481-488.
8. Fennesy M, Metcalfe KA, Hitman GA, Niven MJ, Biro A, Tuomilehto J, Tuomilehto-Wolf E, and the Childhood Diabetes in Finland (DiMe) Study Group: A gene in the HLA class I region contributes to susceptibility to type 1 diabetes in the Finnish population. Diabetetologia 1994;37:937-944.
9. Pitkäniemi J, Onkamo P, Arjas E, Tuomilehto-Wolf E, Tuomilehto J: Estimation of transmission probabilities in families ascertained through a proband with variable age-at-onset disease: Application to the HLA A, B and DR loci in Finnish families with type 1 diabetes. The DiMe Study Group. Hum Hered 2000;50:308-317.
10. Thomas D, Pitkäniemi J, Langholz B, Tuomilehto-Wolf E, Tuomilehto J: Variation in HLA-associated risks of childhood insulin-dependent diabetes in the Finnish population: II. Haplotype effects. DiMe Study Group. Childhood Diabetes in Finland. Genet Epidemiol 1995;12:455-466.
11. Kawabata Y, Ikegami H, Kawaguchi Y, Fujisawa T, Hotta M, Ueda H, Shintani M, Nojima K, Ono M, Nishino M, Taniguchi H, Noso S, Yamada K, Babaya N, Ogihara T: Age-related association of MHC class I chain-related gene A (MICA) with type 1 (insulin-dependent) diabetes mellitus. Hum Immunol 2000;61:624-629.
12. Valdes AM, Thomson G, Erlich HA, Noble JA: Association between type 1 diabetes age of onset and HLA among sibling pairs. Diabetes 1999;48:1658-1661.
13. Spielman RS, McGinnis RE, Ewens WJ: Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993;52:506-516.
14. Li H, Prentice R, Zhao L, Li S: Incorporating Ages at Onset Information into the Transmission/Disequilibrium Test. GAW 12. 2000;209-215.
15. Li H, Hsu L: Effects of age at onset on the power of the affected sib pair and transmission/disequilibrium tests. Ann Hum Genet 2000;64:239-254.
16. Kraft P, Thomas DC: Bias and efficiency in family-based gene-characterization studies: Conditional, prospective, retrospective, and joint likelihoods. Am J Hum Genet 2000;66:1119-1131.
17. Maller R, Zhou X: Survival Analysis with Long-Term Survivors, ed 1. New York, John Wiley & Sons, 1996.
18. Farewell VT: The use of mixture models for the analysis of survival data with long-term survivors. Biometrics 1982;38:1041-1046.
19. Thompson E: Sampling and ascertainment in genetic epidemiology: A tutorial review. Technical report 243, Department of Statistics, University of Washington.
20. Tuomilehto J, Lounamaa R, Tuomilehto-Wolf E, Reunanen A, Virtala E, Kaprio EA, Åkerblom HK: Epidemiology of childhood diabetes mellitus in Finland - background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus. The Childhood Diabetes in Finland (DiMe) Study Group. Diabetologia 1992;35:70-76.
21. Ihaka R, Gentleman RR: A Language for Data Analysis and Graphics. J Computational Graphical Statistics 1996;5:299-314.
22. Bonney GE: Compound regressive models for family data. Hum Hered 1992;42:28-41.
23. Bonney GE: Logistic regression for dependent binary observations. Biometrics 1987;43:951-973.
24. Vaupel JW, Manton KG, Stallard E: The impact of heterogeneity in individual frailty on the dynamics of mortality. Demography 1979;16:439-454.
25. Li H: The additive genetic gamma frailty model for linkage analysis of age-at-onset variation. Ann Hum Genet 1999;63:455-468.
26. Ripatti S, Palmgren J: Estimation of multivariate frailty models using penalized partial likelihood. Biometrics 2000;56:1016-1022.
27. Laird N, Horvath S, Xu X: Implementing a unified approach to family based tests of association. Genetic Epidemiol 2000;19(suppl 1):S36-S42.
28. Cordell HJ, Clayton DG: A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: Application to HLA in type 1 diabetes. Am J Hum Genet 2002;70:124-141.
29. Tuomilehto-Wolf E, Tuomilehto J, Cepaitis C, Lounamaa R, and the DiMe Study Group: New susceptibility haplotype for type 1 diabetes. Lancet 1989;2:299-302.
30. Langholz B, Tuomilehto-Wolf E, Thomas D, Pitkäniemi J, Tuomilehto J, and the DiMe Study Group: Variation in HLA-associated risks of childhood insulin-dependent diabetes in the finnish population: I Allele effects at A, B and DR loci. Genet Epidemiol 1995;12;441-453.